* agilon health inc AGL.N reported a quarterly adjusted
loss
of 41 cents per share for the quarter ended in December, lower
than the same quarter last year, when the company reported EPS
of -14 cents. The mean expectation of fourteen analysts for the
quarter was for a loss of 30 cents per share. Wall Street
expected results to range from -36 cents to -16 cents per share.
* Revenue rose 53.1% to $1.06 billion from a year ago;
analysts
expected $1.02 billion.
* agilon health inc's reported EPS for the quarter was a
loss
of 41 cents.
* The company reported a quarterly loss of $230.43 million.
* agilon health inc shares had fallen by 50.8% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 136.9% in the last three months.
* In the last 30 days, five analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 11
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for agilon
health inc
is $10.00
This summary was machine generated from LSEG data February 27 at
11:33 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.30 -0.41 Missed
Sep. 30 2023 -0.06 -0.08 Missed
Jun. 30 2023 -0.03 -0.04 Missed
Mar. 31 2023 0.02 0.04 Beat